Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c
- PMID:21029304
- DOI: 10.1111/j.1463-1326.2010.01275.x
Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c
Abstract
Steatosis is an accumulation of triglycerides in the liver. Although an excessive availability of plasma fatty acids is an important determinant of steatosis, lipid synthesis from glucose (lipogenesis) is now also considered as an important contributing factor. Lipogenesis is an insulin- and glucose-dependent process that is under the control of specific transcription factors, sterol regulatory element binding protein 1c (SREBP-1c), activated by insulin and carbohydrate response element binding protein (ChREBP) activated by glucose. Insulin induces the maturation of SREBP-1c by a proteolytic mechanism initiated in the endoplasmic reticulum (ER). SREBP-1c in turn activates glycolytic gene expression, allowing glucose metabolism, and lipogenic genes in conjunction with ChREBP. Lipogenesis activation in the liver of obese markedly insulin-resistant steatotic rodents is then paradoxical. Recent data suggest that the activation of SREBP-1c and thus of lipogenesis is secondary in the steatotic liver to an ER stress. The ER stress activates the cleavage of SREBP-1c independent of insulin, thus explaining the paradoxical stimulation of lipogenesis in an insulin-resistant liver. Inhibition of the ER stress in obese rodents decreases SREBP-1c activation and lipogenesis and improves markedly hepatic steatosis and insulin sensitivity. ER is thus a new partner in steatosis and metabolic syndrome which is worth considering as a potential therapeutic target.
© 2010 Blackwell Publishing Ltd.
Similar articles
- GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice.Kammoun HL, Chabanon H, Hainault I, Luquet S, Magnan C, Koike T, Ferré P, Foufelle F.Kammoun HL, et al.J Clin Invest. 2009 May;119(5):1201-15. doi: 10.1172/JCI37007. Epub 2009 Apr 13.J Clin Invest. 2009.PMID:19363290Free PMC article.
- Nutritional related liver disease: targeting the endoplasmic reticulum stress.Kammoun HL, Hainault I, Ferré P, Foufelle F.Kammoun HL, et al.Curr Opin Clin Nutr Metab Care. 2009 Nov;12(6):575-82. doi: 10.1097/MCO.0b013e32833189db.Curr Opin Clin Nutr Metab Care. 2009.PMID:19726979Review.
- Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.Dentin R, Benhamed F, Hainault I, Fauveau V, Foufelle F, Dyck JR, Girard J, Postic C.Dentin R, et al.Diabetes. 2006 Aug;55(8):2159-70. doi: 10.2337/db06-0200.Diabetes. 2006.PMID:16873678
- Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis.McPherson S, Jonsson JR, Barrie HD, O'Rourke P, Clouston AD, Powell EE.McPherson S, et al.J Hepatol. 2008 Dec;49(6):1046-54. doi: 10.1016/j.jhep.2008.06.022. Epub 2008 Jul 15.J Hepatol. 2008.PMID:18752865
- SREBP-1c transcription factor and lipid homeostasis: clinical perspective.Ferré P, Foufelle F.Ferré P, et al.Horm Res. 2007;68(2):72-82. doi: 10.1159/000100426. Epub 2007 Mar 5.Horm Res. 2007.PMID:17344645Review.
Cited by
- Selective inhibition of liver X receptor α-mediated lipogenesis in primary hepatocytes by licochalcone A.Oh GS, Lee GG, Yoon J, Oh WK, Kim SW.Oh GS, et al.Chin Med. 2015 Apr 21;10:8. doi: 10.1186/s13020-015-0037-x. eCollection 2015.Chin Med. 2015.PMID:25937827Free PMC article.
- Mechanism of the effect of glycosyltransferase GLT8D2 on fatty liver.Zhan Y, Zhao F, Xie P, Zhong L, Li D, Gai Q, Li L, Wei H, Zhang L, An W.Zhan Y, et al.Lipids Health Dis. 2015 May 8;14:43. doi: 10.1186/s12944-015-0040-3.Lipids Health Dis. 2015.PMID:25952508Free PMC article.
- Outcomes of SGLT-2i and GLP-1RA Therapy Among Patients With Type 2 Diabetes and Varying NAFLD Status.Bea S, Jeong HE, Filion KB, Yu OH, Cho YM, Lee BH, Chang Y, Byrne CD, Shin JY.Bea S, et al.JAMA Netw Open. 2023 Dec 1;6(12):e2349856. doi: 10.1001/jamanetworkopen.2023.49856.JAMA Netw Open. 2023.PMID:38153732Free PMC article.
- Hydroxypropyl methylcellulose, a viscous soluble fiber, reduces insulin resistance and decreases fatty liver in Zucker Diabetic Fatty rats.Brockman DA, Chen X, Gallaher DD.Brockman DA, et al.Nutr Metab (Lond). 2012 Nov 12;9(1):100. doi: 10.1186/1743-7075-9-100.Nutr Metab (Lond). 2012.PMID:23146593Free PMC article.
- Piperonal prevents high-fat diet-induced hepatic steatosis and insulin resistance in mice via activation of adiponectin/AMPK pathway.Li X, Choi Y, Yanakawa Y, Park T.Li X, et al.Int J Obes (Lond). 2014 Jan;38(1):140-7. doi: 10.1038/ijo.2013.70. Epub 2013 May 7.Int J Obes (Lond). 2014.PMID:23711775
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources